Cargando…
Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy
Hypertrophic obstructive cardiomyopathy can be the phenotype of storage disorders as Fabry disease cardiomyopathy. In this instance, its recognition through GLA gene analysis and preventive administration of enzyme replacement therapy may reduce heart failure risk of surgical septal myectomy (SSM)....
Autores principales: | Frustaci, Andrea, Borghetti, Valentino, Pentiricci, Samuele, Verardo, Romina, Scialla, Rossella, Russo, Matteo Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682850/ https://www.ncbi.nlm.nih.gov/pubmed/37715354 http://dx.doi.org/10.1002/ehf2.14427 |
Ejemplares similares
-
Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy Enhancement
por: Frustaci, Andrea, et al.
Publicado: (2022) -
Circulating Anti-GB3 Antibody as a Biomarker of Myocardial Inflammation in Patients with Fabry Disease Cardiomyopathy
por: Frustaci, Andrea, et al.
Publicado: (2023) -
A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy
por: Iacovoni, Attilio, et al.
Publicado: (2012) -
Surgical Myectomy after Failed Ablation for Hypertrophic Obstructive Cardiomyopathy
por: Bougioukas, Ioannis, et al.
Publicado: (2016) -
Virtual surgical myectomy as a planning tool for obstructive hypertrophic cardiomyopathy
por: Menon, Prahlad G, et al.
Publicado: (2016)